Patent Prosecution
Overview
Technology and the laws meant to protect it—especially the patent laws—are always changing. But the law is not always in sync with technological developments. Companies seeking protection for their state-of-the-art innovations need counsel who not only know what the law is, but where it is likely headed. Crowell & Moring’s team of experienced patent professionals have the experience, knowledge, and judgment to provide such guidance to our clients.
Insights
Client Alert | 4 min read | 04.23.25
Three USPTO Prosecution Announcements Not To Miss
The USPTO has made a series of recent announcements in April that should not go unnoticed as they serve as important reminders for best practices in patent prosecution. In particular, the USPTO’s announcements address continuation applications, a new working group to mitigate fraud, and the elimination of expedited examinations for design applications.
Client Alert | 4 min read | 04.01.25
Hatch-Waxman PTE for Reissue Patents Should Be Calculated From the Original Patent’s Issue Date
Client Alert | 4 min read | 03.27.25
Client Alert | 4 min read | 03.24.25
USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars?
Insights
EV charging stations & connectors: the importance of design patents
|11.15.24
EV Design & Manufacturing
New Momentum For Bill Limiting Contracts With Chinese Biotech Cos.
|07.21.24
Foreign Investment Watch
Professionals
Insights
Client Alert | 4 min read | 04.23.25
Three USPTO Prosecution Announcements Not To Miss
The USPTO has made a series of recent announcements in April that should not go unnoticed as they serve as important reminders for best practices in patent prosecution. In particular, the USPTO’s announcements address continuation applications, a new working group to mitigate fraud, and the elimination of expedited examinations for design applications.
Client Alert | 4 min read | 04.01.25
Hatch-Waxman PTE for Reissue Patents Should Be Calculated From the Original Patent’s Issue Date
Client Alert | 4 min read | 03.27.25
Client Alert | 4 min read | 03.24.25
USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars?
Insights
Client Alert | 4 min read | 04.23.25
Three USPTO Prosecution Announcements Not To Miss
The USPTO has made a series of recent announcements in April that should not go unnoticed as they serve as important reminders for best practices in patent prosecution. In particular, the USPTO’s announcements address continuation applications, a new working group to mitigate fraud, and the elimination of expedited examinations for design applications.
Client Alert | 4 min read | 04.01.25
Hatch-Waxman PTE for Reissue Patents Should Be Calculated From the Original Patent’s Issue Date
Client Alert | 4 min read | 03.27.25
Client Alert | 4 min read | 03.24.25
USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars?